21st Austria weekly - Marinomed, Amag, Uniqa (16/02/2023)

21st Austria weekly - Marinomed Amag Uniqa 16/02/2023 [pic1]Marinomed: Marinomed Biotech AG listed on the Vienna Stock Exchange achieved a further increase in demand for Carragelose products 2022. According to preliminary figures revenues were up by 15.5% € 11.2 m 2021: 9.7 m. This positive development resulted stable of 11.3 full year 11.6 m despite lack milestone payments Adjusted Budesolv payment 1.9 2021 have increased 16.5 %. Cash and cash equivalents 8.2 5.8 m; +41% reflecting low burn-rate throughout 2022 due profitable inflows from loans real estate financings convertible bond program with Nice & Green.Marinomed Biotech:

Related Keywords

Austria ,Vienna ,Wien ,Gerald Mayer ,Austria Metall ,Austria Metall Ag ,Polytec Group ,Uniqa Insurance Group ,Vienna Stock Exchange ,Marinomed Biotech ,Annual General ,Besuchen Sie ,Ic1 Marinomed ,Marinomed ,Biotech ,Bag ,Stock ,Exchange ,Carragelose ,According ,This ,Adjusted ,Budesolv ,Cash ,Nice ,Green Marinomed ,Xbiotech ,